Buy Gemita 1gm Gemcitabine

Gemita 1gm (Gemcitabine) is a chemotherapy medication used for cancer treatment. It belongs to the antimetabolite class and is administered via injection. This vial contains 1 gram of Gemcitabine for intravenous use. Store at 15-25°C in a cool, dry place away from light.

Strength

1gm

Pack Size

Storage

15-25°

Manufacturer / TM Owner

FRESENIUS KABI ONCOLOGY LTD

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Uses / Indications

Gemita 1gm is primarily used to treat various cancers including pancreatic, lung, bladder, and breast cancers. It works by slowing or stopping cancer cell growth. This medication is often prescribed alongside other treatments for better efficacy. Patients often ask what is Gemita 1gm used for when discussing treatment options.

Side Effects

Common effects of Gemita 1gm may include mild nausea, fatigue, or flu-like symptoms after administration. Some patients report temporary hair thinning or changes in appetite. These effects vary and are typically managed with supportive care. Always report persistent or severe reactions to your healthcare provider.

Precautions & Warnings

Gemita 1gm should be handled with care by healthcare professionals. Avoid direct contact with skin or mucous membranes; use protective gloves and clothing. Pregnant or breastfeeding individuals should consult their doctor before exposure. Keep out of reach of children and pets. Follow local guidelines for safe disposal of chemotherapy waste.

Avoid Interactions

Gemita 1gm may interact with other medications, including certain antivirals or immunosuppressants. Alcohol and herbal supplements should be avoided unless approved by a doctor. Radiation therapy or other chemotherapy drugs may require adjusted dosing schedules. Always inform your healthcare provider about all medications you are taking.

References

Frequently Asked Questions

Gemita 1gm (Gemcitabine) is used to treat various cancers, including pancreatic, lung, bladder, and breast cancers.

Gemita 1gm is administered as an intravenous injection by a healthcare professional in a clinical setting.

Common side effects may include nausea, fatigue, or flu-like symptoms after administration.

Yes, Gemita 1gm should be stored at 15-25°C in a cool, dry place away from light.

Pregnant individuals should consult their doctor before exposure to Gemita 1gm due to potential risks.

Published by GNH India Pharmaceuticals Limited

Last updated: 17 Jun 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.